Trending stocks

China Natural Investment Co Ltd reports 680% EBITDA decline in 2020 and 16.2% Revenue decline

25/09/2020 • About China Natural Investment Co Ltd ($8250) • By InTwits

China Natural Investment Co Ltd reported FY2020 financial results today. Here are the key drivers of the company's long term financial model:
  • China Natural Investment Co Ltd is a company in decline: FY2020 revenue growth was -16.2%, 5 years revenue CAGR was -4.2%
  • The company operates at negative EBITDA Margin: -30.5%
  • EBITDA Margin is quite volatile: -30.5% in FY2020, 4.4% in FY2019, -19.2% in FY2018, 0.1% in FY2017, 50.7% in FY2016
  • China Natural Investment Co Ltd has low CAPEX intensity: 5 year average CAPEX/Revenue was 4.8%. At the same time it's in pair with industry average of 4.7%
  • CAPEX is quite volatile: 9 m in FY2020, 19 m in FY2019, 9 m in FY2018, 18 m in FY2017, 24 m in FY2016
  • In the last 5 years the company invested considerably less than D&A: 79 m vs. 118 m. In FY2020 this situation was still the same: CAPEX was 9 while D&A was 24
  • The company has unprofitable business model: ROIC is -20.6%
  • It operates with high leverage: Net Debt/EBITDA is 16.8x while industry average is 37.7x
Below you can find a comprehensive analysis of the key data driving the company's performance and the stock price.

Revenue and profitability


The company's Revenue dropped on 16.2%. Having declining revenue the company managed to increase EBITDA margin. EBITDA Margin jumped on 12.9 pp from -0.46% to 12.4% in FY2020.

Gross Margin decreased on 8.5 pp from 20.1% to 11.7% in FY2020. SG&A as a % of Revenue decreased on 2.4 pp from 20.6% to 18.2% in FY2020.

Net Income margin dropped on 28.7 pp from -9.5% to -38.1% in FY2020.

Investments (CAPEX, working capital and M&A)


The company's CAPEX/Revenue was 3.5% in FY2020. CAPEX/Revenue decreased slightly on 1.1 pp from 4.7% in FY2017 to 3.5% in FY2020. For the last three years the average CAPEX/Revenue was 4.2%.

Return on investment


The company operates at negative ROIC (-20.6%) and ROE (-23.9%). ROIC dropped on 18.5 pp from -2.2% to -20.6% in FY2020. ROE dropped on 18.0 pp from -5.9% to -23.9% in FY2020.

Leverage (Debt)


Debt level is 16.8x Net Debt / EBITDA and Debt / EBITDA. Debt dropped on 95.0% while cash dropped on 19.2%.

China Natural Investment Co Ltd has no short term refinancing risk: cash is higher than short term debt (4,445.8%).

Average interest expence charged on company's debt was 123% in FY2020.

Management team


The company has 606 employees. The number of employees dropped on 61.4%. Average revenue per employee in FY2020 was 437,870 and it jumped on 117%.

Financial and operational results


FY ended 30/06/2020

China Natural Investment Co Ltd ($8250) key annual financial indicators

mln. 201620172018201920202020/2019
P&L
Revenue366.6379.3298.2316.8265.3-16.2%
Gross Profit122.568.060.063.830.9-51.5%
SG&A51.435.264.765.248.3-25.9%
EBITDA185.70.5-57.314.0-80.9-679.8%
EBIT-37.0-86.0-14.0-105.0
Interest expence8.16.97.17.22.0%
Tax-9.1-10.7
Net Income-130.0-140.2-75.7-30.0-101.2
Balance Sheet
Cash216.191.3170.8151.1122.1-19.2%
Short Term Debt0.00.00.00.02.7
Long Term Debt145.3106.6111.8117.33.1-97.3%
Cash flow
Capex24.217.78.519.49.4-51.6%
Ratios
Revenue growth11.6%3.5%-21.4%6.2%-16.2%
EBITDA growth-687.5%-99.7%-11,384.3%-124.3%-679.8%

Gross Margin33.4%17.9%20.1%20.1%11.7%-8.5%
EBITDA Margin50.7%0.1%-19.2%4.4%-30.5%-34.9%
EBIT Margin-9.8%-28.8%-4.4%-39.6%-35.1%
SG&A, % of revenue14.0%9.3%21.7%20.6%18.2%-2.4%
Net Income Margin-35.5%-37.0%-25.4%-9.5%-38.1%-28.7%
CAPEX, % of revenue6.6%4.7%2.9%6.1%3.5%-2.6%

ROIC18.4%-4.5%-12.4%-2.2%-20.6%-18.5%
ROE-19.0%-22.1%-13.8%-5.9%-23.9%-18.0%
Net Debt/EBITDA-0.4x30.1x-2.4x
Interest expence / Average debt6.5%6.3%6.2%123.1%116.9%
People
Employees1,4601,4391,569606-61.4%
Revenue/Employee, th. 260207202438116.9%

Peers in Healthcare-Services


Below we provide China Natural Investment Co Ltd benchmarking against other companies in Healthcare-Services industry for the last 5 years. We show data for the top-5 companies by key financial metric together with the median value for all the companies in the industry.